Faculty: Vera Khokhlova, MD, Mark Emberton, MD and Roland Van Velthoven, MD

Moderators: Avelino Fraga, MD and Tom Polascik, MD


Vera Khokhlova, MD

Vera A. Khokhlova received the M.S. degree in physics, and the Ph.D. and D.Sc. degrees in acoustics from Moscow State University (MSU), Moscow, Russia, in 1986, 1991, and 2012, respectively. After graduation from the Ph.D. program, she was appointed by MSU where she is currently an Associate Professor with the Department of Acoustics of the Physics Faculty.

Since 1995, she has been with the Center for Industrial and Medical Ultrasound of the Applied Physics Laboratory, University of Washington, Seattle, WA, USA. Her fields of expertise include ultrasound-induced mechanical and thermal bioeffects in tissue, shock wave focusing, and numerical modeling of nonlinear acoustic wave propagation in inhomogeneous media.

Dr. Khokhlova has served as a member of the Executive Council of the Acoustical Society of America from 2012 to 2015 and as s member of the Board of the International Society for Therapeutic Ultrasound (2004 - 2008 and 2011 – 2014). She also has served as a member of the Physical Ultrasound Division of the Scientific Council on Acoustics of the Russian Academy of Sciences since 2009 and an Associate Editor of the IEEE UFFC since 2013, co-organized international conferences and schools on therapeutic ultrasound.

Her major research interests are to better understand fundamental nonlinear wave phenomena and to use them in developing new ultrasound medical technologies. She has been leading a team at the University of Washington and MSU working on projects aimed to use nonlinear waves for improving High Intensity Focused Ultrasound (HIFU) therapy, to develop simulation and measurement tools for characterization of HIFU devices, understand bioeffects, facilitate regulatory oversight, and enhance safety and efficacy of HIFU treatment. While working on these projects, a novel method of “boiling histotripsy” (BH) to mechanically ablate tissue using pulsed HIFU was discovered. This technology has gained momentum and already is being explored for various clinical applications including focal therapy of prostate and tumor treatments in kidney.

 

Mark Emberton, MD

Mark Emberton is Professor of Intervention Oncology within the Division of Surgery and Dean of the Faculty of Medical Science at University College London. He is clinically active and holds the position of Honorary Consultant Urologist at University College London Hospitals NHS Trust where he works as a specialist in prostate cancer.
His academic work has focused on developing novel diagnostic strategies and new therapies for men with prostate cancer. His research has resulted in the transformation of both the diagnostic and therapeutic pathways. These have been incorporated into international guidelines.
He has published over 400 peer review papers, holds a large grant portfolio, and lectures widely around the world and holds international honorary professorships.
He is a founding Pioneer of the charity Prostate Cancer UK.

 

Roland Van Velthoven, MD

Degrees and qualifications (specify institutions):


- June 1976 : Graduated MD at Free University of Brussels (ULB)
- Training in Surgery, specialisation in Urology at Free University of Brussels (ULB) from October 1976 till September 1982. Title of specialist in urologic surgery since Octobre 1982.
- Ph.D : Université Libre de Bruxelles, 1997.
- Thesis on contribution de la Microscopie Assistée par ordinateur à la compréhension et à la prévision du comportement biologique des tumeurs de la vessie.
- From 1991 till February 2006 : Head Urology Clinics Institut Jules Bordet – Hôpital Saint-Pierre From March 2006, Head of the Department of Urology, Institut Jules Bordet – Hôpital Saint-Pierre
- Retired from clinical and academic positions on October 1st, 2016
- Consultant urologist, manager of URO-SCIENCE & CONSULTING sincethen
- Visiting Professor in dept Urology, CHU Vaudois , Lausanne CH from 8/1/2018 until 8/31/2021
- Diplôme de Docteur en Médecine, Chirurgie et Accouchements délivré par l'Université Libre de Bruxelles le 30 juin 1976.


Current Position(s):


- Full Member of the European Association of Urology (EAU)
- Board Member of European Society of Uro-technology (ESUT) Corresponding Member of the American Urological Association (AUA)
- Member of the EORTC Genito-Urinary Group
- Corresponding Member of Association Française d’Urologie (AFU) Member of Société Internationale d’Urologie (SIU)
- Permanent member of Collège d’experts de l’Enseignement de la Laparoscopie en Urologie auprès de l’IRCAD-EITS (Faculté de Médecine de Strasbourg)
- More than 140 publications in national and international scientific papers (ref research gate)
- Active participation in national and international congresses in urology with more than 200 presentations (communications and abstracts).

Avelino Fraga, MD

Degrees and qualifications (specify institutions):


- 1986 : Graduated MD at University of Porto 
- 1989-1997: Training in Urology, specialisation in Urology at Hospital Santo António, Porto. Title of specialist in urologic surgery since 1977. 
- 2015: Ph.D Université Porto with thesis on Prostate Cancer and Biomarkers. 
- 2009-2021 Head of Department Urology at Centro Hospitalar Porto
- From 2012: professor of Urology at Medical School of Biomedical Sciencis
- From 2016: Head of Dep of Experimental Surgery at Medical School of Medicine
- 2012-2021: presidente of College Urology at Portuguease Medical Association
- More than 100 publications in national and international scientific papers mainly about Biomarkers in Urologic Cancers
- Active participation in national and international congresses in urology with more than 100  presentations (communications and abstracts). 


Current Position(s):


- Full Member of the European Association of Urology (EAU) 
- Corresponding Member of the American Urological Association (AUA) 
- Member of the EORTC Genito-Urinary Group 
- Member of Société Internationale d’Urologie (SIU)

 

Tom Polascik, MD

Thomas J. Polascik, MD FACS is Professor of Surgery, Duke University Medical Center. He is the Director of Surgical Technology, Duke Prostate and Urological Cancer Center. He is the founder and co-director of the International Symposium on Focal Therapy and Imaging of Prostate and Kidney Cancer that began at Duke in 2008. Dr Polascik is the Editor of the text Imaging and Focal Therapy of Early Prostate Cancer. He currently is the founder and President of the Focal Therapy Society, Duke’s Director of the Society of Urologic Oncology fellowship training program and the Genitourinary Program on Focal Therapy at the Duke Cancer Institute. He is the Medical Director of Duke Men’s Health Initiative Screening event each September and is a governing member of several medical boards and societies. His clinical and research interests focus on prostate and kidney cancer. He has authored over 350 peer-reviewed manuscripts and book chapters.